ibusinesslines.com
ibusinesslines.com June 22, 2018


FDA Approves 1st Home Test for Breast Cancer Genes

07 March 2018, 04:15 | Melissa Porter

23andMe

23andMe

The newly authorized test identifies three of 1000-plus mutations associated with breast cancer risk. No doctor's prescription will be needed for the test. These three mutations, however, are not the most common BRCA1/BRCA2 mutations in the general population.

The test is fairly straightforward.

The test analyzes DNA collected from a self-collected saliva sample, and the report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer.

So, while it is unclear what policy shift caused the FDA's recent change of heart, the announcement it published is jam-packed with caveats, highlighting the limitations of 23andme's now approved DTC test.

"The test only detects three out of more than 1,000 known BRCA mutations".

Of course, the test shouldn't be taken as the be all, end all of cancer risk - nor is it meant as a replacement for a proper screening.

"This test provides information to certain individuals who may be at increased breast, ovarian or prostate cancer risk and who might not otherwise get genetic screening, and is a step forward in the availability of [direct-to-consumer] genetic tests".


The approval comes four years after the FDA threw the brakes on 23andMe's race across the consumer genetic testing landscape in a November 2013 warning letter that amounted to a cease-and-desist order.

Around one in 400 people have BRCA mutations that can cause cancer, and is more common among those with eastern European or Jewish descent. The American Cancer Society says this year, it will be diagnosed in 260,000 women and a few men, and will kill almost 41,000.

The FDA today granted authorization for a direct-to-consumer test for a highly selected group of cancer-associated BRCA mutations.

According to the National Cancer Institute, the three mutations are present in ~2% of Ashkenazi Jewish women compared to 0 - 0.1% in other populations.

"For some people who might be getting this test, it might be hard for people to interpret and understand those results".

The FDA says the test is not a substitute for regular medical checkups and should not be used to make any medical decisions. The agency also outlined special controls created to assure test's accuracy and reliability.



Other News

Trending Now

Putin: Russians Charged in Election Meddling 'May Be Brought to Justice'
US spy chiefs have told 21 states they WERE targeted by Putin's hackers before the 2016 US Presidential election. Putin is seeking a fourth term and faces no significant opposition in the March 18 election.

OPEC to Meet With Hedge Funds' Representatives on CERAweek Sidelines in Houston
Doing so would mean handicapping themselves and ceding even more market share to US shale and other non-OPEC producers. A decision on extending the production limits beyond this year will be made at meetings in June and November, he said.

Police involved in shooting situation in community of Clinton, Mo
A Clinton, Missouri, police officer was fatally shot and two others were injured Tuesday night while responding to an incident. Several media outlets have reported that two Clinton police officers were shot but that their condition was not known.

BYU upends No. 20 Saint Mary's in WCC semifinals
Is the betting total set too high in tonight's conference tournament matchup between Loyola Marymount and Gonzaga at 10:00 p.m. Gonzaga won both meetings with BYU during the regular season, by eight points in Spokane and 14 in Provo.

Lil' Kim Walks Out With Deontay Wilder While Performing 'Spicy'
Add to that he carries his power throughout the fight and isn't afraid to let his hands go when the result is on the line. In the fifth, with boos raining down from the crowd of 14,069 at Barclays Center, Wilder finally landed a solid punch.

Sebastian Vettel of Ferrari quickest as F1 testing resumes in Spain
Kevin Magnussen did not improve on his morning time, which was good enough for the Haas driver to end the day sixth-fastest. In the afternoon the McLaren's lap tally rose to 38 before a hydraulic issue brought the MCL33 to a halt at Turn 3.

Additional security at Excelsior Springs HS after alleged social media threat
We take situations such as this very seriously and will administer tough disciplinary consequences swiftly for such incidents . We know that a safe campus takes all of us working together and I appreciate the support you continue to provide Baseline.